Blood Advances (Sep 2025)
Asciminib for relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia
- Mathilde Chanut,
- Aurélie Cabannes-Hamy,
- Marie Balsat,
- Nassim Sahki,
- Emmanuel Raffoux,
- Yosr Hicheri,
- Bruno Lioure,
- Lucie Laemmel,
- Thibaut Leguay,
- Victoria Cacheux,
- Maria Pilar Gallego-Hernanz,
- Andrea Pieragostini,
- Gabrielle Roth-Guepin,
- Ludovic Gabellier,
- Nathalie Denizon,
- Lise Willems,
- Quentin Cabrera,
- Sylvain Chantepie,
- Valérie Coiteux,
- Claudie Capdupuy,
- Martin Carré,
- Antoine Machet,
- Juliette Lambert,
- Sandrine Roux,
- Franck-Emmanuel Nicolini,
- Nicolas Boissel,
- Emmanuelle Clappier,
- Rathana Kim,
- Philippe Rousselot
Affiliations
- Mathilde Chanut
- Hematology Department, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France; Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France
- Aurélie Cabannes-Hamy
- Hematology Department, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France; Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France
- Marie Balsat
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Hematology Department, Lyon University Hospital, Lyon, France; French Intergroup for Chronic Myelogenous Leukemia, Lyon, France
- Nassim Sahki
- Clinical Research Department, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France
- Emmanuel Raffoux
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Adult Hematology Department, St-Louis Hospital, Assistance Publique–Hôpitaux de Paris, Paris, France
- Yosr Hicheri
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Department of Hematology, Institut Paoli-Calmettes, Marseille, France
- Bruno Lioure
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Department of Onco-Hematology, University of Strasbourg, Institut de Cancérologie Strasbourg Europe, Strasbourg, France
- Lucie Laemmel
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Hematology Department, Bordeaux University Hospital, Pessac, France
- Thibaut Leguay
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Hematology Department, Bordeaux University Hospital, Pessac, France
- Victoria Cacheux
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Hematology Department, Clermont-Ferrand University Hospital, Clermont Ferrand, France
- Maria Pilar Gallego-Hernanz
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Hematology Department, Poitiers University Hospital, Poitiers, France
- Andrea Pieragostini
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Hematology Department, Dijon University Hospital, Dijon, France
- Gabrielle Roth-Guepin
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Hematology Department, Nancy University Hospital, Nancy, France
- Ludovic Gabellier
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Hematology Department, Montpellier University Hospital, Montpellier, France
- Nathalie Denizon
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Hematology Department, Le Mans Hospital, Le Mans, France
- Lise Willems
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Hematology Department, Cochin Hospital, Assistance Publique–Hôpitaux de Paris, Paris, France
- Quentin Cabrera
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Department of Onco-Hematology, La Réunion University Hospital, Saint Pierre, France
- Sylvain Chantepie
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Hematology Department, University Hospital, Caen, France
- Valérie Coiteux
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; French Intergroup for Chronic Myelogenous Leukemia, Lyon, France; Hematology Department, Lille University Hospital, Lille, France
- Claudie Capdupuy
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Hematology Department, Côte Basque Hospital Center, Bayonne, France
- Martin Carré
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Hematology Department, Grenoble University Hospital, Grenoble, France
- Antoine Machet
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Hematology Department, Tours University Hospital, Tours, France
- Juliette Lambert
- Hematology Department, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France
- Sandrine Roux
- Clinical Research Department, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France
- Franck-Emmanuel Nicolini
- French Intergroup for Chronic Myelogenous Leukemia, Lyon, France; Hematology Department, Centre Léon Berard, Lyon, France
- Nicolas Boissel
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Adolescent and Young Adult Hematology Department, Saint-Louis Hospital, Assistance Publique–Hôpitaux de Paris, Paris, France
- Emmanuelle Clappier
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Laboratory of Hematology, Saint-Louis Hospital, Assistance Publique–Hôpitaux de Paris, Paris, France
- Rathana Kim
- Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; Laboratory of Hematology, Saint-Louis Hospital, Assistance Publique–Hôpitaux de Paris, Paris, France
- Philippe Rousselot
- Hematology Department, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France; Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France; French Intergroup for Chronic Myelogenous Leukemia, Lyon, France; Unité de Formation et de Recherche Simone Veil, University Versailles Paris-Saclay, Montigny-le-Bretonneux, France; Correspondence: Philippe Rousselot, Division of Hematology, Centre Hospitalier de Versailles, 177 rue de Versailles, 78150 Le Chesnay, France;
- DOI
- https://doi.org/10.1182/bloodadvances.2025016665
- Journal volume & issue
-
Vol. 9,
no. 18
pp. 4580 – 4584
Abstract
No abstracts available.